経皮的腎結石除去術の市場：コンポーネント、タイプ、エンドユーザー別-2025年～2030年の世界予測

経皮的腎結石除去術市場は、2023年に183億5,000万米ドルと評価され、2024年には196億6,000万米ドルに達すると予測され、CAGR 7.90%で成長し、2030年には312億5,000万米ドルに達すると予測されています。

経皮的腎結石除去術（PCNL）は、体外衝撃波結石破砕術や尿管鏡検査などの他の治療では大きすぎる腎結石を除去するために考案された低侵襲手術法です。皮膚から背中に小さな切開創を作り、腎臓から直接結石を取り出します。PCNLの必要性は主に、大きな腎結石や複雑な腎結石が再発性感染症や強い痛み、尿路閉塞を引き起こしている場合に生じる。PCNLは主に、従来の方法が失敗した場合に適用され、泌尿器科診療所、病院、専門クリニックで不可欠なものとなっています。最終用途の範囲には、熟練した医師と高度な画像処理ツールを備えたヘルスケア施設が多く含まれます。市場の洞察によると、ライフスタイル要因や食習慣に起因する腎臓結石の世界の有病率の増加が、ヘルスケア支出の増加とともにPCNL需要を大きく牽引しています。手術装置の技術的進歩や術後の転帰の改善が、市場の成長をさらに後押ししています。潜在的なビジネスチャンスは、ヘルスケアシステムの拡大が見込まれる新興市場にあり、手術精度を高めるための人工知能やロボット工学への投資は変革をもたらす可能性があります。しかし市場成長は、手術費用の高さ、専門的トレーニングの必要性、出血や感染などの術後合併症といった課題に直面しています。技術革新が必要とされる分野には、より費用対効果の高い手術器具の開発、画像技術の強化、手術へのアクセスを広げるためのトレーニング・モジュールの簡素化などがあります。結石の再発防止に関する調査は、大きな事業成長の展望をもたらす可能性があります。市場競争は依然として続いており、患者の転帰とコスト効率の改善が重視される傾向にあることから、テクノロジーと患者ケアのハイブリッド重視が大きな利益をもたらす可能性があります。したがって、利害関係者は革新的な技術とトレーニング・インフラに戦略を合わせることで、拡大するPCNLの潜在的な市場プレゼンスを最大化すべきです。

市場力学：急速に進化する経皮的腎結石除去術市場の主要市場インサイトを公開

経皮的腎結石除去術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の腎臓結石の増加
  • 病状の早期診断・治療への傾斜
  • 低侵襲な医療処置への嗜好の高まり
• 市場抑制要因
  • 経皮的腎結石除去術機器の技術的問題と高コスト
• 市場機会
  • 経皮的腎結石除去術の革新と進歩
  • 超小型経皮的腎結石除去術の継続的調査
• 市場の課題
  • 経皮的腎結石除去術に関連する合併症とリスク

ポーターの5つの力経皮的腎結石除去術市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、経皮的腎結石除去術市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：経皮的腎結石除去術市場における外部からの影響の把握

外部マクロ環境要因は、経皮的腎結石除去術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析経皮的腎結石除去術市場における競合情勢の把握

経皮的腎結石除去術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス経皮的腎結石除去術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、経皮的腎結石除去術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨経皮的腎結石除去術市場における成功への道筋を描く

経皮的腎結石除去術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で腎臓結石の発生率が上昇
    • 病状の早期診断と治療への傾向
    • 低侵襲医療処置への好意が高まる
  • 抑制要因
    • 技術的な問題と経皮的腎結石除去術機器の高コスト
  • 機会
    • 経皮的腎結石除去術における革新と進歩
    • 超小型経皮腎結石摘出術に関する調査進行中
  • 課題
    • 経皮的腎結石除去術に関連する合併症とリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 経皮的腎結石除去術の市場：コンポーネント別

• アクセサリー
• デバイス
• サービス

第7章 経皮的腎結石除去術の市場：タイプ別

• 微小経皮腎結石摘出術
• ミニ経皮的腎結石除去術
• 超ミニ経皮的腎結石除去術

第8章 経皮的腎結石除去術の市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第9章 南北アメリカの経皮的腎結石除去術の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の経皮的腎結石除去術の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの経皮的腎結石除去術の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advin Urology
• Allengers Medical Systems Ltd.
• Attikouris Enterprises Ltd.
• Boston Scientific Corporation
• Coloplast Corporation
• Cook Group Incorporated
• Dornier MedTech
• E.M.S. Electro Medical Systems S.A.
• EDAP TMS SA
• ELMED Inc.
• Envaste Limited
• Karl Storz Se & Co. KG
• Medical Device Business Services, Inc.
• Medispec Ltd.
• Olympus Corporation
• Richard Wolf GmbH
• Rocamed
• Siemens AG
• Stryker Corporation

LIST OF FIGURES

• FIGURE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET RESEARCH PROCESS
• FIGURE 2. PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PERCUTANEOUS NEPHROLITHOTOMY MARKET DYNAMICS
• TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO-PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA-MINI PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 46. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 101. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 113. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 146. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2023

The Percutaneous Nephrolithotomy Market was valued at USD 18.35 billion in 2023, expected to reach USD 19.66 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 31.25 billion by 2030.

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure designed to remove kidney stones that are too large for other treatments like extracorporeal shock wave lithotripsy or ureteroscopy. It involves creating a small incision in the back through the skin to reach and extract the stone directly from the kidney. The necessity for PCNL arises primarily when large or complicated kidney stones cause recurrent infections, significant pain, or obstruction in the urinary tract. It is primarily applied in procedures where traditional methods fail, making it vital in urology practices, hospitals, and specialized clinics. The end-use scope prominently includes healthcare facilities with skilled practitioners and advanced imaging tools. Market insights reveal that a growing global prevalence of kidney stones, attributed to lifestyle factors and dietary habits, alongside increasing healthcare expenditures, is significantly driving PCNL demand. Technological advancements in surgical devices and improved postoperative outcomes further buoy market growth. Potential opportunities lie in emerging markets with healthcare systems poised for expansion, and investments in artificial intelligence and robotics to enhance surgical precision can be transformative. However, market growth faces challenges like the high cost of the procedure, the requirement for specialized training, and postoperative complications like bleeding or infection. Areas ripe for innovation include the development of more cost-effective surgical tools, enhanced imaging technologies, and simplified training modules to broaden procedure accessibility. Research into preventing stone recurrence could offer significant business growth prospects. The market remains competitive, with a growing emphasis on improving patient outcomes and cost-efficiency, suggesting a hybrid focus on technology and patient care can yield substantial returns. Thus, stakeholders should align their strategies to innovative technologies and training infrastructure to maximize the potential of PCNL's expanding market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Percutaneous Nephrolithotomy Market

The Percutaneous Nephrolithotomy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of kidney stones among individuals worldwide
  • Inclination towards early diagnosis and treatment of medical conditions
  • Growing preference towards minimally invasive medical procedures
• Market Restraints
  • Technical issues and high cost of percutaneous nephrolithotomy equipment
• Market Opportunities
  • Innovations and advancements in percutaneous nephrolithotomy
  • Ongoing research on ultra-mini-percutaneous nephrolithotomy
• Market Challenges
  • Complications and risks associated with percutaneous nephrolithotomy

Porter's Five Forces: A Strategic Tool for Navigating the Percutaneous Nephrolithotomy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Percutaneous Nephrolithotomy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Percutaneous Nephrolithotomy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Percutaneous Nephrolithotomy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Percutaneous Nephrolithotomy Market

A detailed market share analysis in the Percutaneous Nephrolithotomy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Percutaneous Nephrolithotomy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Percutaneous Nephrolithotomy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Percutaneous Nephrolithotomy Market

A strategic analysis of the Percutaneous Nephrolithotomy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Percutaneous Nephrolithotomy Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, Allengers Medical Systems Ltd., Attikouris Enterprises Ltd., Boston Scientific Corporation, Coloplast Corporation, Cook Group Incorporated, Dornier MedTech, E.M.S. Electro Medical Systems S.A., EDAP TMS SA, ELMED Inc., Envaste Limited, Karl Storz Se & Co. KG, Medical Device Business Services, Inc., Medispec Ltd., Olympus Corporation, Richard Wolf GmbH, Rocamed, Siemens AG, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Percutaneous Nephrolithotomy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Accessories, Devices, and Services.
• Based on Type, market is studied across Micro-Percutaneous Nephrolithotomy, Mini Percutaneous Nephrolithotomy, and Ultra-Mini Percutaneous Nephrolithotomy.
• Based on End-Users, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of kidney stones among individuals worldwide
    • 5.1.1.2. Inclination towards early diagnosis and treatment of medical conditions
    • 5.1.1.3. Growing preference towards minimally invasive medical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Technical issues and high cost of percutaneous nephrolithotomy equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations and advancements in percutaneous nephrolithotomy
    • 5.1.3.2. Ongoing research on ultra-mini-percutaneous nephrolithotomy
  • 5.1.4. Challenges
    • 5.1.4.1. Complications and risks associated with percutaneous nephrolithotomy
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Percutaneous Nephrolithotomy Market, by Component

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Devices
• 6.4. Services

7. Percutaneous Nephrolithotomy Market, by Type

• 7.1. Introduction
• 7.2. Micro-Percutaneous Nephrolithotomy
• 7.3. Mini Percutaneous Nephrolithotomy
• 7.4. Ultra-Mini Percutaneous Nephrolithotomy

8. Percutaneous Nephrolithotomy Market, by End-Users

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Clinics
• 8.4. Hospitals

9. Americas Percutaneous Nephrolithotomy Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Percutaneous Nephrolithotomy Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Percutaneous Nephrolithotomy Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advin Urology
• 2. Allengers Medical Systems Ltd.
• 3. Attikouris Enterprises Ltd.
• 4. Boston Scientific Corporation
• 5. Coloplast Corporation
• 6. Cook Group Incorporated
• 7. Dornier MedTech
• 8. E.M.S. Electro Medical Systems S.A.
• 9. EDAP TMS SA
• 10. ELMED Inc.
• 11. Envaste Limited
• 12. Karl Storz Se & Co. KG
• 13. Medical Device Business Services, Inc.
• 14. Medispec Ltd.
• 15. Olympus Corporation
• 16. Richard Wolf GmbH
• 17. Rocamed
• 18. Siemens AG
• 19. Stryker Corporation